Moreover, when treated with Fulvestrant or silenced with siRNA-ERβ, we observed a significant decrease in aggressive property of NSCLC cells and in tumor formation of murin lung cancer metastasis model. This evidence concerns the gene ESR2 and non-small cell lung carcinoma.